Palatinal maxillary canine

K11_MAXIL_CANINE_PALAT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions K11_MAXIL_CANINE_OPER	344
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — K01, K07.35 Hospital discharge: ICD-10 — K01, K07.35 Cause of death: ICD-10 — K01, K07.35 3 out of 7 registries used, show all original rules.	276
4. Check minimum number of events None	276
5. Include endpoints None	276
6. Filter based on genotype QC (FinnGen only)	276

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	K11_MAXIL_CANINE_PALAT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	K11_MAXIL_CANINE_OPER
OUTPAT_ICD	K0735\|K01
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K0735\|K01
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K0735\|K01
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Palatinal maxillary canine based on the number of shared cases.

Similar with more cases:

Palatinal maxillary operation

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8262	5033	3229
Only index persons	8021	4893	3128
Unadjusted period prevalence (%)
Whole population	0.12	0.14	0.09
Only index persons	0.16	0.18	0.12
Median age at first event (years)
Whole population	-	12.56	12.85
Only index persons	12.74	12.63	12.92

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	276	215	61
Unadjusted period prevalence (%)	0.06	0.07	0.03
Median age at first event (years)	13.33	13.17	13.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
236: Matched controls
2357

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ECA00

NOMESCO Finland

Surgical exposure of tooth

14640.1

318.2

234

K01.0

ICD-10 Finland

Embedded teeth

39.4

85.5

110

K01.12

ICD-10 Finland

Retained canine with obstruction in the upper jaw

129.2

81.5

K07.35

ICD-10 Finland

Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth

43.4

65.4

SJD10

NOMESCO Finland

Attachment of arrow to fixed orthodontisk device

10.7

56.5

136

265

SJC01

NOMESCO Finland

Positioning and fixed attachment of single bracket (Bracket with fixed attachment)

10.9

54.8

127

228

SJD00

NOMESCO Finland

Removal or reattacment of arrow in fixed orthodontisk device

10.4

54.5

133

261

SJC50

NOMESCO Finland

Removal of orthodontisk device with at least 7 brackets

8.2

40.9

109

223

SJD20

NOMESCO Finland

Attachment of modifiable arrow of fixed orthodontisk device

7.5

34.1

188

SBB10

NOMESCO Finland

Teeth copy

5.4

32.2

137

478

SJC03

NOMESCO Finland

Positioning and fixed attachment of brackets, extensive

6.1

25.7

183

SJC02

NOMESCO Finland

Positioning and fixed attachment of brackets

6.2

23.5

154

SJD40

NOMESCO Finland

Fixation of ready made palatinal or lingual arrow

4.9

22.6

261

SJD30

NOMESCO Finland

Demanding attachment of arrow to fixed orthodontisk device

6.4

21.5

121

SJB00

NOMESCO Finland

Fitting of loose orthodontic device with user information

4.4

21.4

312

SJX21

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment

4.6

20.8

256

SJC10

NOMESCO Finland

Orthodontic bandage in one tooth

5.2

20.1

177

SJX10

NOMESCO Finland

Short check-up visit for orthodontisk therapy

3.8

19.5

112

454

SJX11

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment, restricted

3.6

16.2

350

SAA04

NOMESCO Finland

Special inverstigation of mouth

3.9

15.3

244

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

6.1

14.3

SAC02

NOMESCO Finland

Separate planning of oral and dental treatment, demanding

4.3

13.6

151

SJC40

NOMESCO Finland

Removal of orthodontisk device with at most 6 brackets

3.5

13.5

260

SXC05

NOMESCO Finland

Other oral or dental procedure

3.3

13.2

305

SJC00

NOMESCO Finland

Bracket with fixed attachment

53.1

13.0

EBA00

NOMESCO Finland

Extraction of tooth

2.6

11.7

139

829

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.7

11.5

155

986

WX110

NOMESCO Finland

Local anesthesy

3.3

10.9

205

1573

EB1MA

NOMESCO Finland

Cephalometry with X-ray

3.2

10.3

227

K01.1

ICD-10 Finland

Impacted teeth

13.0

10.0

SJX20

NOMESCO Finland

Check-up visit for orthodontisk therapy

3.0

9.9

266

K07.30

ICD-10 Finland

Spacing, abnormal of tooth or teeth

3.1

9.9

246

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.2

9.8

215

SAC01

NOMESCO Finland

Separate planning of oral and dental treatment, standard

3.1

9.4

221

OIKK

NOMESCO Finland

2.8

9.4

317

K01.19

ICD-10 Finland

Retained tooth with obstruction barrier UNS

+∞

9.4

OIKH

NOMESCO Finland

3.0

9.1

223

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

5.2

9.1

WZA90

NOMESCO Finland

Other doctors statement

2.3

8.4

105

607

SAA03

NOMESCO Finland

Extended examination of mouth

2.3

8.3

167

1204

SJD50

NOMESCO Finland

Production and attachment of palatinal or lingual arrow

4.8

8.3

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

82.6

7.5

K00.68

ICD-10 Finland

Other disturbance in the tooth eruption

4.2

7.4

OIKAL

NOMESCO Finland

3.6

6.9

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.7

6.9

208

EMAK

NOMESCO Finland

4.8

6.7

K01.10

ICD-10 Finland

Retained front tooth with obstruction in the upper jaw

27.5

6.3

K01.13

ICD-10 Finland

Retained canine with obstruction in the lower jaw

27.5

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

5.55

2.55

4.0

2.1

—

(3000492) Spirometry study

171

1.78

2.06

1.8

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.72

1.73

1.1

1.6

—

(36304419) Bacteria [Presence] in Urine

501

0.63

1.72

4.8

3.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

296

0.55

1.64

1.6

1.9

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

0.00

1.51

0.0

2.1

—

0.18

—

(3030467) Casts [#/volume] in Urine by Automated count

494

0.67

1.44

4.7

3.3

0.07

0.23

e6/l

1.80

358

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.16

1.44

2.6

1.6

—

(3018133) Calcium [Moles/volume] in Urine

2.64

1.37

3.8

2.4

2.39

2.07

mmol/l

—

(3042733) HLA Ab [Presence] in Serum

2.98

1.36

4.8

3.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.98

1.36

1.4

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.81

1.29

1.4

1.1

—

(3018095) Leukocytes [#/volume] in Urine

680

0.73

1.28

5.4

3.8

6.80

96.53

e6/l

3.38

426

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

744

0.74

1.27

2.6

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

443

1.36

1.22

3.1

2.3

2.38

mmol/l

0.05

395

(3048929) Epstein Barr virus Ab [Presence] in Serum

317

0.63

1.19

1.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.34

1.19

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

151

0.52

1.18

1.3

1.5

—

(3000991) Gas panel - Venous blood

200

1.50

1.18

17.8

11.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.53

1.15

5.6

6.8

—

(44806118)

2.41

1.09

2.8

1.4

—

(44790048)

2.41

1.09

2.8

1.4

—

(44790047)

2.41

1.09

2.8

1.4

—

(44790049)

2.41

1.09

2.8

1.4

—

(3008898) HLA-B27 [Presence]

125

0.47

1.07

1.2

1.0

—

(3005033) Fetal Nuchal fold Thickness US

149

0.52

1.07

1.3

1.4

—

(3026782) Osmolality of Urine

340

0.68

1.02

2.7

3.0

655.53

600.33

mosm/kgh2o

0.30

298

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

281

0.65

1.00

1.4

1.2

1.23

8.68

u/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.19

0.98

1.6

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.98

0.0

1.5

—

328.57

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

2.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

243

2516

0.71

0.96

16.1

12.3

133.65

134.31

g/l

0.34

237

2473

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.91

0.94

2.4

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.25

0.94

1.3

1.1

0.81

25.81

u/ml

—

(3045424) Erythrocytes [Presence] in Urine

2.25

0.94

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

177

1.45

0.92

1.2

1.3

460.23

279.73

miu/ml

1.05

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.17

0.92

2.0

2.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.82

0.89

15.2

15.1

0.63

0.69

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

202

0.63

0.86

1.7

1.9

55.03

6.70

u/l

—

157

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.84

0.86

1.0

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

112

0.53

0.85

1.3

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.96

0.85

1.0

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.96

0.85

1.5

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.96

0.85

1.0

1.2

—

(4010399)

1.60

0.83

1.2

1.3

—

(3003338) MCHC [Mass/volume]

197

2084

0.81

0.82

15.3

10.6

333.44

334.16

g/l

0.47

192

2054

(3021447) Carbon dioxide [Partial pressure] in Venous blood

234

1.37

0.82

14.5

8.7

5.87

kpa

0.02

225

(3010813) Leukocytes [#/volume] in Blood

244

2517

0.74

0.82

15.8

12.1

6.79

e9/l

0.01

233

2428

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

127

1142

1.21

0.81

2.4

2.8

34.27

35.75

mmol/mol

1.66

121

1069

(3047352) Trisomy 18 risk [Likelihood] in Fetus

149

0.59

0.81

1.2

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

106

1.54

0.81

24.2

15.9

1.30

1.08

mg/l

0.66

101

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.51

0.79

1.4

—

(3024928) Oxygen saturation in Venous blood

1.84

0.79

9.7

15.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

2.4

—

5.32

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

691

1.22

0.76

12.4

8.8

1.22

mmol/l

0.23

608

(3026361) Erythrocytes [#/volume] in Blood

244

2514

0.75

0.76

15.8

12.1

4.54

4.58

e12/l

0.84

234

2427

(3016244) Insulin [Units/volume] in Serum or Plasma

1.69

0.75

2.7

3.5

22.58

36.92

mu/l

—

(4062490)

2.10

0.75

1.6

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.10

0.75

1.6

2.6

—

(3024731) MCV [Entitic volume]

244

2513

0.75

0.74

15.7

12.1

88.32

87.83

1.05

238

2466

(3035941) MCH [Entitic mass]

244

2513

0.75

0.74

15.8

12.1

29.55

29.45

0.44

238

2466

(3014007) Fractional oxyhemoglobin in Arterial blood

1.63

0.73

16.8

15.1

97.06

95.22

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.69

0.73

2.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.02

0.73

2.6

1.4

—

(3019150) Specific gravity of Urine by Refractometry

489

1.24

0.70

3.9

2.7

1.01

kg/l

0.09

(3019230) Fractional oxyhemoglobin in Venous blood

1.87

0.69

10.2

16.6

68.80

65.97

—

(3013512) EKG study

270

0.72

0.68

2.0

2.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

176

1868

0.84

0.68

12.8

8.4

3.86

3.85

mmol/l

0.34

163

1793

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.80

0.66

1.6

1.2

—

(3007461) Platelets [#/volume] in Blood

244

2508

0.77

0.66

15.8

12.2

269.94

265.67

e9/l

0.48

235

2423

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.64

0.66

2.5

2.2

—

(36660697) Celiac disease serology panel - Serum

307

1.28

0.65

1.3

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

217

1.32

0.65

2.3

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

533

1.21

0.62

4.6

3.1

0.00

0.01

estimate

0.80

223

(40760892) CBC W Ordered Manual Differential panel - Blood

536

0.81

0.62

5.5

3.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

187

1968

0.85

0.62

4.3

4.0

1.71

1.81

mu/l

0.84

176

1853

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.59

0.61

1.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1.52

0.61

2.7

2.9

90.00

100.74

ml/min/173m2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.9

—

0.65

—

(3015183) Erythrocyte sedimentation rate

0.00

0.60

0.0

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

227

2347

0.82

0.60

4.1

4.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

0.59

0.0

3.2

—

132.33

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.58

0.59

1.8

2.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.73

0.58

2.7

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

143

1532

0.86

0.58

7.2

5.7

108.39

112.14

ml/min/173m2

0.91

1054

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1.50

0.58

19.0

15.4

23.13

23.40

mmol/l

—

(3000494) Fungus identified in Specimen by Culture

150

1.36

0.57

1.7

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

142

1.36

0.56

2.2

1.7

—

(4198724)

1.64

0.56

2.0

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

178

1873

0.86

0.55

12.6

8.4

139.33

139.47

mmol/l

0.43

165

1805

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

205

1.30

0.55

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.59

0.54

1.2

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1064

0.86

0.53

2.7

2.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

102

1114

0.87

0.52

10.5

6.2

32.24

32.37

0.05

1058

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.51

0.52

1.7

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

113

1222

0.87

0.50

12.1

7.3

3.82

3.78

e9/l

0.07

1062

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

107

0.65

0.49

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

288

0.78

0.49

1.2

8.70

16.27

iu/ml

—

(3021589) Normoblasts [#/volume] in Blood

1029

0.87

0.49

12.2

7.5

0.00

e9/l

0.00

831

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

738

1.16

0.49

4.2

2.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

105

1140

0.87

0.49

2.3

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

627

0.85

0.49

2.2

2.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

564

0.84

0.48

4.3

3.6

—

(3044889) 12 lead EKG panel

925

0.87

0.48

2.4

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

219

1.26

0.47

15.4

8.3

5.31

4.87

kpa

0.42

211

(3009542) Hematocrit [Volume Fraction] of Blood

215

2221

0.86

0.46

13.5

9.7

39.42

40.05

0.73

185

1899

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.44

0.46

16.7

24.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

655

0.86

0.46

1.5

1.6

—

(40761511) CBC panel - Blood by Automated count

221

2278

0.85

0.46

8.5

7.0

—

(3019198) Lymphocytes [#/volume] in Blood

106

1146

0.88

0.46

10.6

6.2

2.06

2.04

e9/l

0.10

1027

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

197

0.75

0.46

11.1

5.3

5.05

8.28

umol/l

0.70

156

(3013707) Erythrocyte sedimentation rate by Westergren method

130

1386

0.88

0.45

3.7

3.6

7.14

7.49

mm/h

0.21

123

1270

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

444

0.83

0.45

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1001

0.88

0.44

2.4

2.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

194

1.26

0.43

1.3

380.13

360.23

u/ml

0.03

183

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

195

0.76

0.43

1.3

1.4

—

(1616796) Gas panel - Central venous blood

1.57

0.42

4.2

4.9

—

(3000850) Epithelial cells [#/volume] in Urine

367

0.83

0.42

2.6

2.8

8.78

11.65

e6/l

0.71

319

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

194

0.76

0.42

1.3

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

451

0.84

0.41

2.1

2.8

156.07

76.65

ug/g

0.41

331

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

168

1758

0.89

0.41

3.8

3.5

14.22

14.32

pmol/l

0.22

150

1562

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.41

0.0

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.41

0.0

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.41

0.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.41

0.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.40

0.0

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.44

0.39

1.6

1.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

111

1187

0.89

0.39

7.3

4.9

82.71

84.02

u/l

0.11

104

1101

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

2.4

—

17.18

—

(40768793) Breast Pathology biopsy report

0.00

0.39

0.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.39

0.0

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

461

1.16

0.38

1.9

1.6

—

(3020891) Body temperature

1.40

0.38

3.6

4.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

112

0.71

0.38

1.0

1.5

2.30

3.71

ug/l

—

104

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

143

1.28

0.38

2.2

1.6

—

(3000330) Specific gravity of Urine by Test strip

0.65

0.36

3.0

1.7

—

(3011288) Drugs identified in Urine by Screen method

265

0.82

0.36

1.2

2.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.44

0.36

1.3

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

102

1091

0.90

0.36

10.4

6.0

53.22

53.90

0.25

1035

(3044290) Cell count panel - Cerebral spinal fluid

1.40

0.35

1.0

2.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.37

0.34

2.0

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

182

1.23

0.34

5.2

6.7

1.20

0.96

mmol/l

0.16

119

(40761535) Cells panel - Urine sediment

100

1.31

0.34

4.4

3.0

—

(40758558) Short blood count panel - Blood

515

0.87

0.33

10.2

5.9

—

(42870588) Differential panel, method unspecified - Blood

709

1.12

0.33

11.3

6.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

201

2070

0.89

0.33

8.9

6.6

23.59

23.70

u/l

0.03

190

1978

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

143

0.76

0.33

1.7

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

110

1.29

0.32

1.8

2.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

296

1.17

0.32

1.6

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

643

1.12

0.31

14.2

9.0

1.23

1.22

mmol/l

0.19

602

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.36

0.31

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

585

1.12

0.31

3.0

2.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

810

0.90

0.31

2.0

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

185

0.80

0.31

2.3

2.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.28

0.30

2.6

2.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

204

1.19

0.30

17.4

11.9

24.41

24.86

mmol/l

0.30

204

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

158

1517

1.10

0.30

2.4

2.2

5.14

5.34

mmol/l

3.56

152

1372

(3021879) Hepatitis B virus core Ab [Presence] in Serum

269

0.84

0.29

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

103

1091

0.91

0.29

2.3

2.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

194

0.81

0.28

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

194

0.81

0.28

1.3

1.4

—

(3022313) Gas panel - Capillary blood

149

1.22

0.28

5.6

7.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

140

1.23

0.28

6.0

6.7

10.24

9.97

kpa

0.23

131

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

224

0.84

0.26

1.2

1.5

—

(4035726)

1.24

0.25

1.2

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

137

0.79

0.25

1.6

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

227

1.16

0.25

1.7

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

1.32

0.23

2.2

2.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

212

2164

0.91

0.23

10.8

8.6

22.00

21.18

mg/l

0.13

157

1530

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.26

0.23

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

199

0.84

0.22

1.5

—

(3032080) INR in Blood by Coagulation assay

397

0.89

0.22

3.1

3.5

1.01

1.04

inr

0.85

154

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.0

—

1.86

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.21

0.0

15.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

5.2

—

10.32

—

(3019309) Folate [Moles/volume] in Red Blood Cells

145

1.18

0.21

1.4

1.6

1015.20

1012.26

nmol/l

—

114

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

662

0.92

0.21

9.7

5.5

9.80

10.40

umol/l

0.21

600

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.26

0.21

1.6

1.7

—

(3022621) pH of Urine by Test strip

118

1.20

0.19

2.1

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.16

0.19

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.16

0.19

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

271

1.12

0.19

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

166

1.16

0.18

1.7

2.0

—

(1761868) Lipid panel - Serum or Plasma

525

1.08

0.18

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

102

979

1.07

0.17

6.0

4.2

0.00

estimate

0.00

227

(3013115) Eosinophils [#/volume] in Blood

107

1111

0.94

0.17

11.4

6.8

0.17

0.18

e9/l

0.50

989

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.11

0.17

1.3

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.72

0.17

1.8

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.18

0.16

1.1

—

(3006315) Basophils [#/volume] in Blood

104

1078

0.94

0.15

10.7

6.4

0.04

0.03

e9/l

0.11

941

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

213

0.88

0.15

1.8

2.0

—

(40761536) Microorganisms panel - Urine sediment

212

0.89

0.14

4.3

3.4

—

(3009261) Glucose [Presence] in Urine by Test strip

102

985

1.06

0.14

4.5

3.1

0.00

estimate

0.00

224

(3001604) Monocytes [#/volume] in Blood

104

1075

0.95

0.14

10.7

6.4

0.52

e9/l

0.01

938

(3001019) Free T4 and TSH panel - Serum or Plasma

0.83

0.14

1.3

—

(3002256) Pathology report gross observation

159

0.87

0.13

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

277

1.09

0.13

1.2

1.3

—

(40768804) Tissue Pathology biopsy report

503

1.07

0.13

2.0

1.6

—

(3006504) Eosinophils/100 leukocytes in Blood

100

1032

0.95

0.12

10.6

6.5

2.69

2.76

0.12

969

(3019069) Monocytes/100 leukocytes in Blood

101

1042

0.95

0.12

10.6

6.6

8.04

8.03

0.01

986

(3003694) ABO and Rh group [Type] in Blood

880

0.95

0.12

1.7

1.8

—

(3035350) Ketones [Presence] in Urine by Test strip

101

980

1.05

0.11

4.5

3.0

0.00

estimate

0.00

217

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

126

0.87

0.11

2.9

2.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

454

0.94

0.11

5.6

2.9

—

(3044640) Blood type and Crossmatch panel - Blood

535

1.06

0.11

3.0

2.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

129

1262

1.04

0.10

3.0

2.8

49.08

45.20

ug/l

0.22

123

1177

(1001926) Buprenorphine [Presence] in Urine by Screen method

321

1.07

0.09

1.7

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

196

0.91

0.09

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

139

1365

1.04

0.08

4.9

3.8

—

(3022948) Iron [Moles/volume] in Serum or Plasma

234

1.08

0.08

3.7

2.6

12.95

14.86

umol/l

0.69

218

(3023511) Choriogonadotropin [Units/volume] in Urine

234

1.08

0.08

1.6

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.14

0.08

1.5

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

882

0.96

0.08

4.4

4.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.80

0.07

1.2

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

147

1.09

0.07

6.3

6.9

23.26

24.35

mmol/l

0.53

147

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.86

0.07

1.3

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.02

0.07

2.6

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

404

1.05

0.06

2.0

2.4

3595.05

5946.95

u/l

0.41

150

(3019832) Treponema pallidum Ab [Presence] in Serum

788

0.97

0.06

1.7

1.8

—

(3027944) Amphetamines [Presence] in Urine

395

1.04

0.06

1.7

1.8

—

(3022096) Basophils/100 leukocytes in Blood

988

0.97

0.06

10.8

6.7

0.53

0.60

0.72

934

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

100

1.10

0.05

1.1

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

327

1.05

0.05

1.9

7.17

11.03

ng/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

141

1427

0.98

0.05

2.4

2.3

2.54

2.67

mmol/l

1.20

135

1332

(3042936) Bacteria identified in Isolate by Culture

179

1.07

0.05

2.1

2.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

120

1.09

0.05

2.8

2.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

765

1.03

0.04

1.5

1.75

1.77

g/l

0.04

442

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

413

0.96

0.04

3.4

2.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

150

0.93

0.04

1.1

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

123

1215

1.02

0.04

5.0

3.2

29.40

24.67

u/l

0.33

118

1157

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

230

1.05

0.03

1.4

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

963

0.98

0.03

6.6

5.5

5.97

5.92

mmol/l

0.10

824

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

181

1.05

0.03

4.7

2.8

17.08

24.17

1.95

164

(3025941) Bacteria identified in Stool by Culture

128

0.93

0.02

1.1

—

(3027008) Opiates [Presence] in Urine

401

1.03

0.02

1.7

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

900

0.98

0.02

1.5

1.6

1.36

2.17

u/ml

0.50

198

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

202

1.04

0.02

2.0

2.7

338.13

725.94

ng/l

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.08

0.02

4.3

2.7

1.23

mmol/l

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

103

1.07

0.02

2.5

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

117

0.94

0.02

1.5

—

(3028300) Cannabinoids [Presence] in Urine

402

1.02

0.01

1.7

1.8

—

(21494755) Public health laboratory ask at order entry panel

207

0.96

0.01

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

293

1.03

0.01

5.6

3.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

141

1417

0.99

0.01

2.4

2.3

1.43

mmol/l

0.09

136

1331

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

106

0.94

0.01

1.4

1.3

—

(3022145) Colonoscopy Study observation

116

0.95

0.00

1.7

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

166

0.96

0.00

1.6

1.9

45.74

6.77

iu/l

—

128

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

356

0.98

0.00

4.3

2.7

1.20

1.01

mg/l

0.11

220

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

504

1.01

0.00

1.3

1.4

91.04

97.64

pmol/l

0.59

273

(40768797) Stomach Pathology biopsy report

152

0.99

0.00

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

241

1.00

0.00

1.4

1.3

131.97

110.43

iu/ml

—

(3000764) Benzodiazepines [Presence] in Urine

399

1.00

0.00

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

451

1.00

0.00

1.5

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

117

1.03

0.00

3.1

4.4

—

0.52

—

(3026008) Bacteria identified in Urine by Culture

623

0.99

0.00

2.6

2.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

106

1.04

0.00

10.9

4.9

148.18

172.99

0.47

100

(3015736) pH of Urine

783

0.99

0.00

4.6

2.7

—

(3018418) pH of Serum or Plasma

376

1.01

0.00

9.8

3.1

7.38

7.39

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.00

0.00

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.92

0.00

1.1

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40768443) Skin Pathology biopsy report

0.84

0.00

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

110

1.00

0.00

1.2

1.1

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

32.67

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

4.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

10.60

—

(3049717) Cytology report of Urine Cyto stain

0.00

0.0

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

0.0

2.4

—

1.13

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

2.6

—

750.40

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.0

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.0

30.2

—

0.61

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.94

0.00

1.0

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.00

0.0

3.4

—

9.26

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.0

1.0

—

6.40

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.89

0.00

1.2

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.92

0.00

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

25.93

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

0.0

1.3

—

(3045414) Leukocytes [Presence] in Urine

0.91

0.00

1.9

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.0

2.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3006270) Folate [Moles/volume] in Blood

0.00

0.0

1.2

—

418.33

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

350

1.00

0.00

2.8

1.5

1.23

1.36

1.20

320

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

9.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

3.8

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

39.33

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.0

8.3

—

(3019225) pH of Specimen

110

1.00

0.00

1.2

4.0

—

(3016879) Cocaine [Presence] in Urine

370

1.00

0.00

1.8

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

4.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.96

0.00

1.8

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.0

9.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.4

—

(4146454)

0.00

0.0

3.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

2.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.01

0.00

1.1

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

17.65

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

0.00

0.0

1.0

—

1.24

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_MAXIL_CANINE_PALAT and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_MAXIL_CANINE_PALAT.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: K11_MAXIL_CANINE_PALAT – Palatinal maxillary canine

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Palatinal maxillary canine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints